This article is dedicated to the study of post-COVID dermatitis in military personnel, with a focus on clinical-immunological indicators and preventive measures. The study addresses the primary symptoms of dermatological manifestations resulting from a previous COVID-19 infection, including skin rashes, inflammation, and itching, as well as immunological changes such as alterations in cytokine and antibody levels. Special attention is given to the analysis of risk factors such as stress, exposure to physical and climatic conditions, and the immune response peculiarities in military personnel that may exacerbate the development of skin diseases after infection. Recommendations for preventing post-COVID dermatitis are provided, including the use of specialized dermatological products, immune system support, psychological recovery, as well as the importance of early diagnosis and timely treatment.

post-COVID dermatitis, military personnel, COVID-19, SARS-CoV-2, CD3+, CD4+, CD8+, NK cells.

World Health Organization. Clinical Management of COVID-19: Interim Guidance. Geneva: WHO; 2021.

Ministry of Health of the Russian Federation. Temporary Guidelines: Prevention, Diagnosis, and Treatment of New Coronavirus Infection (COVID-19). Version 14. Moscow; 2022.

Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615.

Yong SJ. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737–754.

Freeman EE, McMahon DE, Lipoff JB, et al. The Spectrum of COVID-19–Associated Dermatologic Manifestations: An International Registry. J Am Acad Dermatol. 2020;83(4):1118–1129.

Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous Manifestations in COVID-19: Lessons Learned from Current Evidence. J Am Acad Dermatol. 2020;83(1):e57–e60.

Genovese G, Moltrasio C, Berti E, Marzano AV. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology. 2021;237(1):1–12.

Tang K, Wang Y, Zhang H, et al. Cutaneous Manifestations of the Coronavirus Disease 2019 (COVID-19): A Brief Review. Dermatol Ther. 2020;33(4):e13528.

McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous Manifestations of COVID-19: A Systematic Review. JAAD Int. 2021;2:119–132.

Herman A, Peeters C, Verroken A, et al. Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic. JAMA Dermatol. 2020;156(9):998–1003.

Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary Manifestations of COVID-19. Nat Med. 2020;26(7):1017–1032.

Mazurov V.I., Petrova O.V. Immunopathogenesis and Clinical Manifestations of COVID-19. Therapeutic Archive. 2021;93(3):4–11.

Fedorova N.Yu., Bazhenov D.V. Dermatological Aspects of New Coronavirus Infection. Russian Journal of Skin and Venereal Diseases. 2021;24(3):155–161.

Ahmed H, Patel K, Greenwood DC, et al. Long-Term Clinical Outcomes in Survivors of Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome Coronavirus Outbreaks After Hospitalization: A Systematic Review and Meta-Analysis. J Rehabil Med. 2020;52(5):jrm00063.

Kim J, Kim S, Kim HJ, et al. Long COVID in South Korea: National Cohort Study on Risk of Autoimmune Skin Diseases. JAMA Dermatol. 2023;159(5):490–498.

Lallas A, Kyrgidis A, Papageorgiou C, et al. COVID-19 and the Skin: Pathophysiology and Clinical Management. Clin Dermatol. 2021;39(1):82–89.